|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
14 Pt 1
|
|
pubmed:dateCreated |
2006-7-21
|
|
pubmed:abstractText |
Breast carcinomas expressing basal epithelium cytokeratins constitute a tumor subgroup that is typically hormone receptor negative and shows a distinct gene expression profile. Based on variable basal cytokeratin immunostaining patterns, we hypothesized that the "basal phenotype" tumor group may comprise more than one biological entity.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4185-91
|
|
pubmed:meshHeading |
pubmed-meshheading:16857790-Aged,
pubmed-meshheading:16857790-Breast Neoplasms,
pubmed-meshheading:16857790-Carcinoma,
pubmed-meshheading:16857790-Cohort Studies,
pubmed-meshheading:16857790-Disease-Free Survival,
pubmed-meshheading:16857790-Female,
pubmed-meshheading:16857790-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:16857790-Humans,
pubmed-meshheading:16857790-Image Processing, Computer-Assisted,
pubmed-meshheading:16857790-Keratin-14,
pubmed-meshheading:16857790-Keratin-5,
pubmed-meshheading:16857790-Keratins,
pubmed-meshheading:16857790-Male,
pubmed-meshheading:16857790-Middle Aged,
pubmed-meshheading:16857790-Prognosis
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Basoluminal carcinoma: a new biologically and prognostically distinct entity between basal and luminal breast cancer.
|
|
pubmed:affiliation |
Department of Pathology, Seinäjoki Central Hospital, Seinäjoki, Finland. mervi.laakso@epshp.fi
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
